Regeneron joins $100M round for DNAnexus and its cloud-computing DNA software

[cafead]

via DNAnexus has been accruing capital and customers for over a decade, since the DNA computing company spun out of Stanford in 2009. Now, two years after their last funding round, the company has raised its largest round yet, at $100 million, and secured what may be its most intriguing investor: Regeneron Pharmaceuticals.

article source